JEREMY
DUFLOO -
INVEST CONT PROYECTO EUROPEO
Centre National de la Recherche Scientifique
París, FranciaPublicaciones en colaboración con investigadores/as de Centre National de la Recherche Scientifique (7)
2022
-
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Journal of Experimental Medicine, Vol. 219, Núm. 7
2021
-
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
Cell Reports Medicine, Vol. 2, Núm. 5
-
SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation
EMBO Journal, Vol. 40, Núm. 24
2020
-
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Science Translational Medicine, Vol. 12, Núm. 559
-
Flow cytometry analysis of HIV-1 env conformations at the surface of infected cells and virions: Role of Nef, CD4, and SERINC5
Journal of Virology, Vol. 94, Núm. 6
-
Syncytia formation by SARS-CoV-2-infected cells
EMBO Journal, Vol. 39, Núm. 23
2018
-
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
Cell Reports, Vol. 23, Núm. 9, pp. 2568-2581